Electrophysiological Effects of Tipranavir Co-administered With Ritonavir on the QT Interval in Healthy Female and Male Subjects
NCT02248883 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 81
Last updated 2014-09-25
Summary
To demonstrate that tipranavir (TPV) co-administered with ritonavir (RTV) does not affect the QT interval more than placebo co-administered with ritonavir
Conditions
- Healthy
Interventions
- DRUG
-
TPV low
- DRUG
- DRUG
-
Moxifloxacin
- DRUG
-
TPV high
- DRUG
-
RTV
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-12-31
- Primary Completion
- 2006-03-31
More Related Trials
-
Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers
NCT02243553 ·Status: COMPLETED ·Phase: PHASE1
-
Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval
NCT04821063 ·Status: COMPLETED ·Phase: PHASE1
-
A Placebo-controlled Four Way Crossover Study to Asses the Effect of a Single Oral Dose of NKTR-118 on QTc Interval in Healthy Male Subjects
NCT01325415 ·Status: COMPLETED ·Phase: PHASE1
-
Tolerability and Potential ECG Effects After a Single Oral Dose of Pentoxyverine Citrate in Healthy Male and Female Volunteers
NCT02183649 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Two Different Oral Solutions Tipranavir Administered in Combination With Ritonavir to Healthy Volunteers
NCT02244190 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female Participants
NCT04423744 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants.
NCT05878522 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of BI 1356 as Single Dose on the QT Interval in Healthy Female and Male Subjects
NCT02183467 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male Subjects
NCT02253797 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Interaction Between Tipranavir and BILR 355 BS Plus Ritonavir in Healthy Male Volunteers
NCT02257021 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of a Single-dose Administration of BIBW 2992 and Multiple-dose Administration of Ritonavir in Healthy Volunteers
NCT02171754 ·Status: COMPLETED ·Phase: PHASE1
-
Thorough QT/QTc (TQT) Clinical Study to Evaluate the Effects of Ziresovir on Cardiac Repolarization in Healthy Subjects
NCT06591845 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
This Study in Healthy Men and Women Tests Whether BI 409306 Has an Effect on the ECG (Thorough QT Study)
NCT03934203 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Tipranavir Stored at Controlled Temperature Compared With Tipranavir Stored at Controlled Refrigerated Conditions, Orally Co-administered With Ritonavir in Healthy Male and Female Volunteers
NCT02253888 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects
NCT02534870 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy Subjects
NCT05293171 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Evaluate The Effect Of Single Intravenous Doses Of Tigecycline On QTc Intervals In Healthy Subjects
NCT01287793 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities
NCT06107036 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of TPV/r on the Pharmacokinetics of Carbamazepine in Healthy Adult Volunteers
NCT02253849 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of Tipranavir/Ritonavir Paediatric Solution Compared to Tipranavir/Ritonavir Capsules in Healthy Female and Male Subjects
NCT02251158 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TMC647055 in Combination With Ritonavir (Part 1) and the Co-administration of TMC435, TMC647055 and Ritonavir (Part 2) in Healthy Japanese Participants
NCT02064842 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers
NCT02293148 ·Status: COMPLETED ·Phase: PHASE1
-
Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Subjects.
NCT01965431 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of RO6889678 and the Combination of RO6889678 With Ritonavir in Healthy Participants
NCT02321384 ·Status: TERMINATED ·Phase: PHASE1
-
A Thorough QT Study of ABBV-CLS-7262 in Healthy Subjects
NCT06310876 ·Status: COMPLETED ·Phase: PHASE1